D. E. Shaw & Co. Inc. boosted its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 44.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 87,184 shares of the company's stock after purchasing an additional 27,028 shares during the quarter. D. E. Shaw & Co. Inc. owned approximately 0.58% of U.S. Physical Therapy worth $7,734,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. CBIZ Investment Advisory Services LLC lifted its position in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after buying an additional 122 shares in the last quarter. Venturi Wealth Management LLC grew its position in U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after acquiring an additional 704 shares during the last quarter. Pacer Advisors Inc. bought a new position in U.S. Physical Therapy in the 4th quarter valued at $113,000. Aquatic Capital Management LLC raised its holdings in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after purchasing an additional 198 shares in the last quarter. Finally, Mutual of America Capital Management LLC bought a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at about $203,000.
Insiders Place Their Bets
In related news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. The trade was a 19.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of research firms have commented on USPH. JMP Securities reiterated a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. cut their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Barrington Research lowered their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Finally, William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $109.00.
Check Out Our Latest Stock Analysis on U.S. Physical Therapy
U.S. Physical Therapy Price Performance
NYSE USPH traded down $0.03 during mid-day trading on Monday, hitting $79.81. The stock had a trading volume of 108,229 shares, compared to its average volume of 110,821. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $107.09. The company has a market cap of $1.21 billion, a price-to-earnings ratio of 84.90, a P/E/G ratio of 3.54 and a beta of 1.44. The company has a 50 day simple moving average of $71.85 and a 200 day simple moving average of $83.57. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business's revenue for the quarter was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.51 earnings per share. Equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.
U.S. Physical Therapy Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio is presently 82.57%.
U.S. Physical Therapy Profile
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.